TrialMicrobiology spectrum2023

A Phase 2 Randomized Trial Evaluating the Antiviral Activity and Safety of the Direct-Acting Antiviral Bemnifosbuvir in Ambulatory Patients with Mild or Moderate COVID-19 (MOONSONG Study).

Marta Boffito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.